Research ArticleArticle
Cross-cultural Validation of a Disease-specific Patient-reported Outcome Measure for Systemic Lupus Erythematosus in Canada
Josiane Bourré-Tessier, Ann E. Clarke, Rachel A. Mikolaitis-Preuss, Mark Kosinski, Sasha Bernatsky, Joel A. Block and Meenakshi Jolly
The Journal of Rheumatology June 2013, jrheum.121129; DOI: https://doi.org/10.3899/jrheum.121129
Josiane Bourré-Tessier
From the Department of Medicine, Division of Rheumatology, and Division of Clinical Immunology/Allergy, and Division of Clinical Epidemiology, McGill University Health Center, Montréal, Québec, Canada; Division of Rheumatology, Rush University Medical Center, Chicago, Illinois; and QualityMetric Inc., Outcomes Insight Consulting Division, Lincoln, Rhode Island, USA. J. Bourré-Tessier, MD, MSc, Department of Medicine, Division of Rheumatology, McGill University Health Center (MUHC); A.E. Clarke, MD, MSc, Department of Medicine, Division of Clinical Immunology/Allergy, MUHC; R.A. Mikolaitis-Preuss, MSc, Division of Rheumatology, Rush University Medical Center; M. Kosinski, MS, QualityMetric Inc., Outcomes Insight Consulting Division; S. Bernatsky, MD, PhD, Division of Clinical Immunology/Allergy, and Division of Clinical Epidemiology, MUHC; J.A. Block, MD; M. Jolly, MD, MSc, Division of Rheumatology, Rush University Medical Center. Address correspondence to Dr. M. Jolly, Rush University Medical Center, Chicago, IL 60615, USA. E-mail: Meenakshi_Jolly@rush.edu Accepted for publication April 22, 2013.
Ann E. Clarke
From the Department of Medicine, Division of Rheumatology, and Division of Clinical Immunology/Allergy, and Division of Clinical Epidemiology, McGill University Health Center, Montréal, Québec, Canada; Division of Rheumatology, Rush University Medical Center, Chicago, Illinois; and QualityMetric Inc., Outcomes Insight Consulting Division, Lincoln, Rhode Island, USA. J. Bourré-Tessier, MD, MSc, Department of Medicine, Division of Rheumatology, McGill University Health Center (MUHC); A.E. Clarke, MD, MSc, Department of Medicine, Division of Clinical Immunology/Allergy, MUHC; R.A. Mikolaitis-Preuss, MSc, Division of Rheumatology, Rush University Medical Center; M. Kosinski, MS, QualityMetric Inc., Outcomes Insight Consulting Division; S. Bernatsky, MD, PhD, Division of Clinical Immunology/Allergy, and Division of Clinical Epidemiology, MUHC; J.A. Block, MD; M. Jolly, MD, MSc, Division of Rheumatology, Rush University Medical Center. Address correspondence to Dr. M. Jolly, Rush University Medical Center, Chicago, IL 60615, USA. E-mail: Meenakshi_Jolly@rush.edu Accepted for publication April 22, 2013.
Rachel A. Mikolaitis-Preuss
From the Department of Medicine, Division of Rheumatology, and Division of Clinical Immunology/Allergy, and Division of Clinical Epidemiology, McGill University Health Center, Montréal, Québec, Canada; Division of Rheumatology, Rush University Medical Center, Chicago, Illinois; and QualityMetric Inc., Outcomes Insight Consulting Division, Lincoln, Rhode Island, USA. J. Bourré-Tessier, MD, MSc, Department of Medicine, Division of Rheumatology, McGill University Health Center (MUHC); A.E. Clarke, MD, MSc, Department of Medicine, Division of Clinical Immunology/Allergy, MUHC; R.A. Mikolaitis-Preuss, MSc, Division of Rheumatology, Rush University Medical Center; M. Kosinski, MS, QualityMetric Inc., Outcomes Insight Consulting Division; S. Bernatsky, MD, PhD, Division of Clinical Immunology/Allergy, and Division of Clinical Epidemiology, MUHC; J.A. Block, MD; M. Jolly, MD, MSc, Division of Rheumatology, Rush University Medical Center. Address correspondence to Dr. M. Jolly, Rush University Medical Center, Chicago, IL 60615, USA. E-mail: Meenakshi_Jolly@rush.edu Accepted for publication April 22, 2013.
Mark Kosinski
From the Department of Medicine, Division of Rheumatology, and Division of Clinical Immunology/Allergy, and Division of Clinical Epidemiology, McGill University Health Center, Montréal, Québec, Canada; Division of Rheumatology, Rush University Medical Center, Chicago, Illinois; and QualityMetric Inc., Outcomes Insight Consulting Division, Lincoln, Rhode Island, USA. J. Bourré-Tessier, MD, MSc, Department of Medicine, Division of Rheumatology, McGill University Health Center (MUHC); A.E. Clarke, MD, MSc, Department of Medicine, Division of Clinical Immunology/Allergy, MUHC; R.A. Mikolaitis-Preuss, MSc, Division of Rheumatology, Rush University Medical Center; M. Kosinski, MS, QualityMetric Inc., Outcomes Insight Consulting Division; S. Bernatsky, MD, PhD, Division of Clinical Immunology/Allergy, and Division of Clinical Epidemiology, MUHC; J.A. Block, MD; M. Jolly, MD, MSc, Division of Rheumatology, Rush University Medical Center. Address correspondence to Dr. M. Jolly, Rush University Medical Center, Chicago, IL 60615, USA. E-mail: Meenakshi_Jolly@rush.edu Accepted for publication April 22, 2013.
Sasha Bernatsky
From the Department of Medicine, Division of Rheumatology, and Division of Clinical Immunology/Allergy, and Division of Clinical Epidemiology, McGill University Health Center, Montréal, Québec, Canada; Division of Rheumatology, Rush University Medical Center, Chicago, Illinois; and QualityMetric Inc., Outcomes Insight Consulting Division, Lincoln, Rhode Island, USA. J. Bourré-Tessier, MD, MSc, Department of Medicine, Division of Rheumatology, McGill University Health Center (MUHC); A.E. Clarke, MD, MSc, Department of Medicine, Division of Clinical Immunology/Allergy, MUHC; R.A. Mikolaitis-Preuss, MSc, Division of Rheumatology, Rush University Medical Center; M. Kosinski, MS, QualityMetric Inc., Outcomes Insight Consulting Division; S. Bernatsky, MD, PhD, Division of Clinical Immunology/Allergy, and Division of Clinical Epidemiology, MUHC; J.A. Block, MD; M. Jolly, MD, MSc, Division of Rheumatology, Rush University Medical Center. Address correspondence to Dr. M. Jolly, Rush University Medical Center, Chicago, IL 60615, USA. E-mail: Meenakshi_Jolly@rush.edu Accepted for publication April 22, 2013.
Joel A. Block
From the Department of Medicine, Division of Rheumatology, and Division of Clinical Immunology/Allergy, and Division of Clinical Epidemiology, McGill University Health Center, Montréal, Québec, Canada; Division of Rheumatology, Rush University Medical Center, Chicago, Illinois; and QualityMetric Inc., Outcomes Insight Consulting Division, Lincoln, Rhode Island, USA. J. Bourré-Tessier, MD, MSc, Department of Medicine, Division of Rheumatology, McGill University Health Center (MUHC); A.E. Clarke, MD, MSc, Department of Medicine, Division of Clinical Immunology/Allergy, MUHC; R.A. Mikolaitis-Preuss, MSc, Division of Rheumatology, Rush University Medical Center; M. Kosinski, MS, QualityMetric Inc., Outcomes Insight Consulting Division; S. Bernatsky, MD, PhD, Division of Clinical Immunology/Allergy, and Division of Clinical Epidemiology, MUHC; J.A. Block, MD; M. Jolly, MD, MSc, Division of Rheumatology, Rush University Medical Center. Address correspondence to Dr. M. Jolly, Rush University Medical Center, Chicago, IL 60615, USA. E-mail: Meenakshi_Jolly@rush.edu Accepted for publication April 22, 2013.
Meenakshi Jolly
From the Department of Medicine, Division of Rheumatology, and Division of Clinical Immunology/Allergy, and Division of Clinical Epidemiology, McGill University Health Center, Montréal, Québec, Canada; Division of Rheumatology, Rush University Medical Center, Chicago, Illinois; and QualityMetric Inc., Outcomes Insight Consulting Division, Lincoln, Rhode Island, USA. J. Bourré-Tessier, MD, MSc, Department of Medicine, Division of Rheumatology, McGill University Health Center (MUHC); A.E. Clarke, MD, MSc, Department of Medicine, Division of Clinical Immunology/Allergy, MUHC; R.A. Mikolaitis-Preuss, MSc, Division of Rheumatology, Rush University Medical Center; M. Kosinski, MS, QualityMetric Inc., Outcomes Insight Consulting Division; S. Bernatsky, MD, PhD, Division of Clinical Immunology/Allergy, and Division of Clinical Epidemiology, MUHC; J.A. Block, MD; M. Jolly, MD, MSc, Division of Rheumatology, Rush University Medical Center. Address correspondence to Dr. M. Jolly, Rush University Medical Center, Chicago, IL 60615, USA. E-mail: Meenakshi_Jolly@rush.edu Accepted for publication April 22, 2013.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Cross-cultural Validation of a Disease-specific Patient-reported Outcome Measure for Systemic Lupus Erythematosus in Canada
Josiane Bourré-Tessier, Ann E. Clarke, Rachel A. Mikolaitis-Preuss, Mark Kosinski, Sasha Bernatsky, Joel A. Block, Meenakshi Jolly
The Journal of Rheumatology Jun 2013, jrheum.121129; DOI: 10.3899/jrheum.121129
Cross-cultural Validation of a Disease-specific Patient-reported Outcome Measure for Systemic Lupus Erythematosus in Canada
Josiane Bourré-Tessier, Ann E. Clarke, Rachel A. Mikolaitis-Preuss, Mark Kosinski, Sasha Bernatsky, Joel A. Block, Meenakshi Jolly
The Journal of Rheumatology Jun 2013, jrheum.121129; DOI: 10.3899/jrheum.121129